JPMorgan Chase & Co’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $339 | Sell |
|
|||||
|
2025
Q1 | $290 | Sell |
|
|||||
|
2024
Q4 | $271 | Buy |
|
|||||
|
2024
Q3 | $486 | Hold |
|
|||||
|
2024
Q2 | $471 | Hold |
|
|||||
|
2024
Q1 | $671 | Hold |
|
|||||
|
2023
Q4 | $659 | Sell |
|
|||||
|
2023
Q3 | $945 | Hold |
|
|||||
|
2023
Q2 | $1.29K | Sell |
|
|||||
|
2023
Q1 | $1.19K | Sell |
|
|||||
|
2022
Q4 | $2K | Buy |
|
|||||
|
2022
Q3 | $2K | Sell |
|
|||||
|
2022
Q2 | $4K | Sell |
|
|||||
|
2022
Q1 | $97K | Buy |
|
|||||
|
2021
Q4 | $74K | Sell |
|
|||||
|
2021
Q3 | $240K | Buy |
|
|||||
|
2021
Q2 | $352K | Sell |
|
|||||
|
2021
Q1 | $887K | Sell |
|
|||||
|
2020
Q4 | $815K | Sell |
|
|||||
|
2020
Q3 | $21.2M | Buy |
|
|||||
|
2020
Q2 | $16.3M | Sell |
|
|||||
|
2020
Q1 | $20.4M | Sell |
|
|||||
|
2019
Q4 | $47.7M | Sell |
|
|||||
|
2019
Q3 | $72.3M | Buy |
|
|||||
|
2019
Q2 | $48.6M | Sell |
|
|||||
|
2019
Q1 | $99.5M | Buy |
|
|||||
|
2018
Q4 | $75.6M | Sell |
|
|||||
|
2018
Q3 | $136M | Buy |
|
|||||
|
2018
Q2 | $125M | Buy |
|
|||||
|
2018
Q1 | $95.8M | Buy |
|
|||||
|
2017
Q4 | $119M | Sell |
|
|||||
|
2017
Q3 | $113M | Buy |
|
|||||
|
2017
Q2 | $82.7M | Buy |
|
|||||
|
2017
Q1 | $98.8M | Buy |
|
|||||
|
2016
Q4 | $77.3M | Buy |
|
|||||
|
2016
Q3 | $73.7M | Sell |
|
|||||
|
2016
Q2 | $98.4M | Buy |
|
|||||
|
2016
Q1 | $52.9M | Buy |
|
|||||
|
2015
Q4 | $46.8M | Sell |
|
|||||
|
2015
Q3 | $29.8M | Buy |
|
|||||
|
2015
Q2 | $1.47M | Buy |
|
|||||
|
2015
Q1 | $1.12M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $32K | Sell |
|
|||||
|
2013
Q2 | $170K | Buy |
|